15th Georg RAJKA ISAD Presentation: Zabalafin Hydrogel – A Novel Topical Botanical Drug That Addresses the Four Demons of Atopic Dermatitis

15th Georg RAJKA International Symposium on Atopic Dermatitis Presentation: Zabalafin Hydrogel – A Novel Topical Botanical Drug That Addresses the Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics October 27, 2025, 07:30 ET 1168_Neal-KOLLER_phase-2b-trial-of-zabalafin-hydrogel-a-novel-topical-botanical-drug-that-addresses-the-four-demons-of-atopic-dermatitis CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

EADV Congress 2025 Poster Presentation: Zabalafin Hydrogel – A Novel, Safe, and Effective Topical Botanical Drug That Comprehensively Addresses the Four Demons of Atopic Dermatitis

EADV Congress 2025 Poster Presentation: Zabalafin Hydrogel – A Novel, Safe, and Effective Topical Botanical Drug That Comprehensively Addresses the Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics September 23, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

2025 Integrative Dermatology Summit Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis

2025 Integrative Dermatology Summit Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics August 12, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

50th Annual Society for Pediatric Dermatology Meeting Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis

50th Annual Society for Pediatric Dermatology Meeting Poster Presentation: Zabalafin Hydrogel, A Novel Topical Botanical Drug That Addresses The Four Demons of Atopic Dermatitis NEWS PROVIDED BY Alphyn Biologics July 22, 2025, 07:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195

2025 European Society for Pediatric Dermatology (EPSD) Poster Presentation: Phase 2 trial of topical drug zabalafin treating mild to moderate atopic dermatitis

2025 European Society for Pediatric Dermatology (EPSD) Poster Presentation: Phase 2 trial of topical drug zabalafin treating mild to moderate atopic dermatitis, starting with infection in children and adults NEWS PROVIDED BY Alphyn Biologics May 29, 2025, 19:30 ET CONTACTS   Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687   Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195